Predictive Impact of
Journal
JCO precision oncology
ISSN: 2473-4284
Titre abrégé: JCO Precis Oncol
Pays: United States
ID NLM: 101705370
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
medline:
2
11
2023
pubmed:
5
10
2023
entrez:
5
10
2023
Statut:
ppublish
Résumé
Target therapy (TT) with encorafenib plus cetuximab is a standard option in patients with A retrospective cohort of patients with pMMR/MSS One hundred thirty-two patients with pMMR/MSS Patients with pMMR/MSS
Substances chimiques
RNF43 protein, human
EC 2.3.2.27
Ubiquitin-Protein Ligases
EC 2.3.2.27
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM